Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Equity

v3.22.4
Consolidated Statements of Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings/(Accumulated Deficit)
Retained Earnings/(Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income/(Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares, Outstanding     94          
Balance as of beginning of period, value at Dec. 31, 2019 $ 1,212 $ (10) $ 1 $ (363) $ 1,488 $ 113 $ (10) $ (27)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) (132)         (132)    
Other comprehensive income (loss) (25)             (25)
Dividends, Common Stock (53)         (53)    
Stock Repurchased During Period, Shares     (1)          
Other (45)     (45)        
Net Share Settlement of Incentive Equity Awards (4)       (4)      
Net income 21       21      
Stockholders' Equity, Other (1)       (1)      
Balance as of end of period, value at Dec. 31, 2020 963   $ 1 (408) 1,504 (82)   (52)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares, Outstanding     93          
Net income/(loss) 244         244    
Other comprehensive income (loss) 37             37
Dividends, Common Stock (83)         (83)    
Stock Repurchased During Period, Shares     (2)          
Other (110)     (110)        
Net Share Settlement of Incentive Equity Awards (7)       (7)      
Net income 28       28      
Stock Issued During Period, Value, Stock Options Exercised 17       17      
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures     1          
Stock Issued During Period, Value, Restricted Stock Award, Gross 0              
Stockholders' Equity, Other 0     (1) 1      
Balance as of end of period, value at Dec. 31, 2021 1,089   $ 1 (519) 1,543 79   (15)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares, Outstanding     92          
Net income/(loss) 355              
Other comprehensive income (loss) 53             53
Dividends, Common Stock (116)         (116)    
Stock Repurchased During Period, Shares     (6)          
Other (445)     (445)        
Net Share Settlement of Incentive Equity Awards (11)       (11)      
Net income 33       33      
Stock Issued During Period, Value, Stock Options Exercised 4       4      
Balance as of end of period, value at Dec. 31, 2022 $ 962   $ 1 $ (964) $ 1,569 $ 318   $ 38
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares, Outstanding     86